| GUEST EDITORIAL
International Journal of Aesthetic and Anti-Ageing Medicine Informa Healthcare, 119 Farringdon Road, London, EC1R 3DA, UK
www.informahealthcare.com ISSN 2159-8908 (print) ISSN 2159-8916 (online)
Managing Editor Rosalind Hill
rosalind.hill@informa.com
Sub-Editor Balraj Juttla
balraj.juttla@informa.com
Publisher Simon Percival +44(0)20 7017 4060
simon.percival@
informa.com
European Sales Manager Mat Eaton +44(0)20 7017 4315
mat.eaton@informa.com
Business Development Manager NA Meg McNeel +1 (212) 520 2745
meg.mcneel@
informausa.com
Senior Marketing Executive Susie Comben
susie.comben@
informa.com
Production Editor John Oliver
john.oliver@informa.com
Managing Director Nick Del Rio
nick.delrio@
informausa.com
Web Designer/Producer Marcus Hurley +44 (0)20 7017 4252
marcus.hurley@
informa.com
Art Director David ‘Spike’ McCormack
spike@spikedesigns.co.uk
Production & Ads Department
primeadverts@informa.com
Please send your manuscripts and press releases to:
rosalind.hill@informa.com
■ All manuscripts submitted to the journal are first evaluated on the basis of scientific quality, originality, appropriateness, contribution to the field and style. Suitable manuscripts are then subject to rigorous peer review.
■ Formal submissions for peer reviewed papers/ Articles. Manuscripts and accompanying files should be prepared in accordance with our Author Guidelines, which are available via
www.prime-journal.com)
All content © 2013 Informa UK Ltd Images ©
Shutterstock.com, unless otherwise stated
the later stages, symptoms may be triggered by excessive sun exposure, emotional triggers, spicy foods, wind, hot or cold water, alcohol, oral contraceptive pills, hormonal influence, or topical corticosteroids. The erythematotelangiectatic variation can often be accompanied by burning or stinging, with
R
affected areas of the face appearing rough to the touch due to the low grade dermatitis. Some theories propose the causes of rosacea are neurogenic and vasogenic in origin. Patients with
rosacea have also been noted to have defective skin barriers and increased transepidermal water loss in the skin. A deposition of cathelicidin-derived peptides caused by serine protease activity may play a role in the inflammatory process. The integrity of blood vessels is reduced by the action of elastase, which degrades extracellular matrix and type IV collagen and the reduction of upper dermal connective tissue results in passive dilation of the vasculature, causing telangiectasia. Several treatments are available for rosacea. Topical and oral medications include topical
metronidazole, benzoyl peroxide, tetracyclines such as doxycycline and isotretinoin for treating inflammatory lesions, and topical vitamin C preparations to help protect against free radical production in inflammation. The mainstream treatment for rosacea is lasers. The intense pulse light (IPL) laser uses photothermolysis
and specific wavelengths to selectively destroy blood vessels. Energy density is customised based on the lesion being treated. Light wavelengths in the range of 500–1200 nm are emitted with larger vessels requiring higher fluences of between 50–75 J/cm2 fluences ranging from 25–45 J/cm2
, while smaller vessels can be successfully treated at . Pulses are delivered as single, double, or triple with each pulse lasting
2–25 ms for larger vessels. Pulse durations should be maintained between 0.5–88.5 ms with an interval ranging from 10–500 ms. The IPL laser can allow a large surface area to be treated. With pulse delays and the ability to adjust the number of pulses delivered, the skin can be cooled between pulses preventing adverse effects from occurring, such as burning of the skin or pigmentation changes. Retrospective studies have found IPL treatment to be a safe and effective treatment for the symptoms
of redness, flushing, and telangiectasias, while also improving skin texture and resulting in fewer acneiform breakouts with virtually no adverse effects. On average, relief of symptoms was seen after seven treatment sessions. Set at specific parameters and customised according to patient skin type, severity of rosacea, and tolerance to treatment, IPL therapy can help patients achieve a relief from symptoms. Overall, IPL treatments can provide long lasting results with no downtime, making this an excellent choice for treating rosacea.
Ramtin Kassir and Margaret Karsky Plastic Surgeon; Laser Fellow
PRIME JOURNAL EDITORIAL BOARD BOARD MEMBER SPECIALISM
Dr Claude Dalle
Dr Wilmar Accursio Dr Pierre Andre Dr Ashraf Badawi
Anti-ageing & aesth. medicine France Endocrinology Dermatology Dermatology
France Egypt
Dr Janethy Balakrishnan Dermatology Dr Lakhdar Belhaouari Dr Philippe Berros Dr Dario Bertossi
Dr Philippe Blanchemaison Phlebology Dr Pierre Bouhanna Dr Fahd Benslimane Prof Wayne Carey
Dr Claude Chauchard Dr Olivier Claude
Dr Christophe de Jaeger Geriatrics Dr Jacques Dequesne Prof Ilaria Ghersetich Dr Kate Goldie
Dr Monika Golkova Prof Eckart Haneke Dr Steven Hopping
Plastic surgery
Oculoplastic surgery Maxillofacial surgery
Dermatology – Hair surgery Plastic Surgery Dermatology
Anti-ageing medicine Plastic surgery
Gynaecology Dermatology
Aesthetic dermatology Neurology
Dermatology Plastic surgery
Prof Andreas Katsambas Dermatology Dr Mario Krause Dr David Lai
Anti-ageing medicine Anti-ageing medicine
Malaysia France
Monaco Italy
France France
Morocco Canada France France France France Italy UK
Czech Republic Germany USA
Greece Germany Hong Kong
COUNTRY Brazil
BOARD MEMBER SPECIALISM Dr Marina Landau
Dermatology
Dr Gustavo Leibaschoff Dr Jean-Luc Levy Dr Sohail Mansoor Prof Leonardo Marini
Prof Daniel Pella
Cosmetic surgery Dermatology Dermatology Dermatology
Prof Dr Martino Neumann Dermatology & Venereology Dr Sly Nedic
Dr Chariya Petchngaovilai Dermatology Prof Ascanio Polimeni Dr Herve Raspaldo Dr Neil Sadick
Dr Hema Sundaram Dr Pakpilai Thavisin Dr Patrick Treacy Dr Mario Trelles Dr Ines Verner Dr Octavio Viera
Dr Jean-Luc Vigneron Prof Bernard Weber Dr Sabine Zenker
Catherine Decuyper Wendy Lewis
Christophe Luino
Neuro-endocrinology Facial plastic surgery Dermatology
Cosmetic dermatology
COUNTRY Israel
USA
France UK
Italy
Aesthetic & anti-ageing medicine South Africa Cardiology
Netherlands Slovakia
Thailand Italy
France USA USA
Dermatology & Anti-ageing medicine Thailand Aesthetic surgery Plastic surgery Dermatology
Anti-ageing medicine Aesthetic dermatology Genetics
Dermatology
Ireland Spain Israel Spain
France
Luxembourg Germany
Industry expert & consultant France Industry expert
USA Industry expert & consultant France
prime-journal.com | March 2013 ❚ 5
OSACEA IS A CHRONIC SKIN CONDITION AFFECTING THE AESTHETIC APPEARANCE of the skin. It affects both men and women, predominantly those between 30–50 years of age. The degree of severity varies from mild flushing to severe telangiectatic lesions depending on the subtype of this condition. Presentation varies in the early stages from symptoms of blushing and erythema to dilated blood vessels of 0.1–1.5 mm in diameter, otherwise known as telangiectasias. In
Reference Kassir R, Kolluru A, Kassir M. Intense Pulsed Light for the Treatment of Rosacea and Telangiectasias. Journal of Cosmetic and Laser Therapy. August 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140